20:46:42 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



V:RX - BioSyent Inc. - https://www.biosyent.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RX - V  0.813.61·13.900.713.69-0.16-1.29.01197813.90  13.90  13.5815.80  10.6515:59:00May 1915 min RT 2¢
TSX-V - V0.813.61·13.900.713.70-0.15-1.12.9391813.90  13.90  13.7015.80  10.6513:07:2415 min
NEO ATS - U 13.58-0.27-1.90.34213.70  13.70  13.5813:07:2415 min
Alpha - A 13.61-0.24-1.70.68513.77  13.89  13.5815:37:3515 min
Omega - O 13.69-0.16-1.20.11113.69  13.69  13.6915:59:0015 min
CXC - X 13.90+0.050.40.11113.90  13.90  13.9010:04:1915 min
CX2 - H 13.77-0.08-0.60.11113.77  13.77  13.7713:05:3115 min
CXD - D 13.89+0.040.31.8232113.78  13.89  13.5914:55:3615 min
MatchNOW - M 13.852.02624    Sep 11-2015 min
Lynx - Y 13.69-0.16-1.21.115513.87  13.87  13.6915:59:0015 min

Recent Trades - Last 10 of 78
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:00Y13.69-0.1630079 CIBC80 National BankK
15:59:00O13.69-0.161001 Anonymous80 National BankK
15:37:35A13.61-0.2410079 CIBC222 JP MorganK
15:28:37D13.900.059822 Fidelity2 RBCE
15:12:58D13.900.0515124 Questrade7 TD SecE
14:55:36M13.890.0410014 Virtu ITG1 Anonymous
14:55:36D13.890.0410014 Virtu ITG79 CIBCK
14:55:36M13.890.0410014 Virtu ITG2 RBC
14:55:36D13.890.0430014 Virtu ITG2 RBCK
14:55:36D13.890.0430014 Virtu ITG2 RBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-05-19 09:52C:RX14.44News ReleaseBioSyent Announces Health Canada Approval of Thyconvi(TM) (levothyroxine oral solution)
2026-05-14 18:01C:RX14.43News ReleaseBioSyent Declares Second Quarter 2026 Dividend
2026-05-14 18:00C:RX14.43News ReleaseBioSyent Releases Financial Results for First Quarter 2026
2026-05-14 15:10C:RX14.43SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-05-14 15:10C:RX14.43SEDAR Interim MD & ASEDAR Interim MD & A
2026-05-07 18:11C:RX14.64News ReleaseBioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026
2026-04-23 09:06C:RX15.00SEDAR Annual ReportSEDAR Annual Report
2026-04-15 08:40C:RX14.88News ReleaseBioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-03-24 21:18C:RX14.70News ReleaseBioSyent grants 44,222 RSUs
2026-03-19 17:30C:RX15.50News ReleaseBioSyent Releases Financial Results for Fourth Quarter and Full Year 2025
2026-03-19 13:47C:RXSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2026-03-19 13:47C:RXSEDAR MD & ASEDAR MD & A
2026-03-13 04:59C:RX15.70News ReleaseBioSyent to release 2025 results March 19
2026-03-02 21:07C:RX15.74News ReleaseBioSyent closes Oral Science acquisition, grants RSUs
2026-03-02 18:43C:RX15.74AcquisitionBioSyent acquisition of Oral Science
2026-02-09 17:54C:RX13.76News ReleaseBioSyent to acquire Oral Science for $25.5-million
2026-01-29 16:30C:RX12.75News ReleaseBioSyent Declares First Quarter 2026 Dividend
2025-12-16 18:23C:RX12.10Normal Course Issuer BidBioSyent normal course issuer bid
2025-12-15 21:02C:RX12.02News ReleaseBioSyent renews share buyback
2025-11-20 17:30C:RX10.72News ReleaseBioSyent Releases Financial Results for Q3 and YTD 2025